Overexpression of PTEN may increase the effect of pemetrexed on A549 cells via inhibition of the PI3K/AKT/mTOR pathway and carbohydrate metabolism-Reference-Cited by-同舟云学术

Overexpression of PTEN may increase the effect of pemetrexed on A549 cells via inhibition of the PI3K/AKT/mTOR pathway and carbohydrate metabolism

Published:2019-08-26 Issue: Volume: Page:
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:
Short-container-title:Mol Med Report

Author:

Li Bo¹,Zhang Junkai²,Su Ya³,Hou Yiling⁴,Wang Zhenguo⁵,Zhao Lin⁶,Sun Shengkai⁵,Fu Hao⁷

Affiliation:

1. Department of Thoracic Medicine, Chest Hospital, Tianjin 300051, P.R. China

2. Logistics University of Chinese People's Armed Police Force, Tianjin 300309, P.R. China

3. Neurology Department, Pingjin Hospital, Tianjin 300162, P.R. China

4. Physical Examination Center, Pingjin Hospital, Tianjin 300162, P.R. China

5. Medical Research Department, Pingjin Hospital, Tianjin 300162, P.R. China

6. Department of Geriatric Medicine, Fourth People's Hospital of Shanghai Affiliated to Tongji University School of Medicine, Shanghai 200081, P.R. China

7. Department of Geriatric Medicine, Pingjin Hospital, Tianjin 300162, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lentinan mitigates pemetrexed chemoresistance by the PI3K/Akt pathway in non-small cell lung cancer;Cell Biochemistry and Biophysics;2024-05-15

2. MiR-320a upregulation contributes to the effectiveness of pemetrexed by inhibiting the growth and invasion of human lung cancer cell line (Calu-6);Molecular Biology Reports;2024-02-19

3. Therapeutic Implications of PTEN in Non-Small Cell Lung Cancer;Pharmaceutics;2023-08-05

4. Synthetic RNA Therapeutics in Cancer;Journal of Pharmacology and Experimental Therapeutics;2023-05-15

5. The Potential Application of Branch‐PCR Assembled PTEN Gene Nanovector in Lung Cancer Gene Therapy;ChemBioChem;2022-09-27